alendronate has been researched along with Glomerulosclerosis, Focal Segmental in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a case of collapsing focal segmental glomerulosclerosis and severe kidney dysfunction in a liver transplant recipient after the initiation of alendronate for osteopenia." | 7.74 | Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate. ( Djamali, A; Musat, A; Myers, J; Pascual, J; Samaniego, M; Tome, S; Torrealba, J, 2007) |
| "We describe a case of collapsing focal segmental glomerulosclerosis and severe kidney dysfunction in a liver transplant recipient after the initiation of alendronate for osteopenia." | 3.74 | Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate. ( Djamali, A; Musat, A; Myers, J; Pascual, J; Samaniego, M; Tome, S; Torrealba, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miura, N | 1 |
| Mizuno, N | 1 |
| Aoyama, R | 1 |
| Kitagawa, W | 1 |
| Yamada, H | 1 |
| Nishikawa, K | 1 |
| Imai, H | 1 |
| Pascual, J | 1 |
| Torrealba, J | 1 |
| Myers, J | 1 |
| Tome, S | 1 |
| Samaniego, M | 1 |
| Musat, A | 1 |
| Djamali, A | 1 |
2 other studies available for alendronate and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Massive proteinuria and acute renal failure after oral bisphosphonate (alendronate) administration in a patient with focal segmental glomerulosclerosis.
Topics: Acute Kidney Injury; Administration, Oral; Alendronate; Blood Component Removal; Bone Density Conser | 2009 |
Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate.
Topics: Alendronate; Bone Density Conservation Agents; Bone Diseases, Metabolic; Glomerulosclerosis, Focal S | 2007 |